CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2012
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Revenues	$ 647,814		$ 640,867		$ 690,741
Cost of goods sold	522,340		502,375		557,938
Gross profit	125,474		138,492		132,803
Selling, general and administrative expenses	87,756		79,707		76,961
Research and development expenses	7,608		7,615		6,286
Amortization of intangible assets	779		1,659		2,599
Restructuring and relocation expenses			3,927
Operating income	29,331		45,584		46,957
Gain on settlement			(1,709)
Other income (See Note E)	(1,522)
Interest expense	178		202		272
Interest income	(13)		(35)		(114)
Income from continuing operations before income taxes	30,688		47,126		46,799
Income tax provision	11,068		7,387		18,056
Income from continuing operations	19,620		39,739		28,743
Income from discontinued operations, net of tax (Note N)	9,604		2,337		914
Net income	$ 29,224		$ 42,076		$ 29,657
Earnings per share:
Continuing operations	$ 1.63		$ 3.32		$ 2.43
Discontinued operations	$ 0.80		$ 0.20		$ 0.07
Basic earnings per share	$ 2.43	[1]	$ 3.52	[2]	$ 2.50
Continuing operations	$ 1.62		$ 3.32		$ 2.41
Discontinued operations	$ 0.80		$ 0.19		$ 0.08
Diluted earnings per share	$ 2.42	[1]	$ 3.51	[2]	$ 2.49
Weighted average shares:
Basic	12,003		11,948		11,850
Diluted	12,058		11,994		11,925
Dividends per share	$ 1.00

[1] The increase in earnings per share for the second quarter of Fiscal 2014 was primarily due to the sale of Transdyn. For additional information on this disposition, see Note N.

[2] The increase in earnings per share for the fourth quarter of Fiscal 2013 was primarily driven by the release of our Canadian valuation allowance. For an explanation of the effective tax rate in Fiscal 2013, see Note H.